What is Celebrex?
Celebrex is the brand name for celecoxib, a non-steroidal antiinflammatory used to relieve the pain, swelling and stiffness of osteoarthritis and adult rheumatoid arthritis; to treat of primary dysmenorrhea; and to reduce intestinal polyps in the inherited disorder adenomatous polyposis.
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Pain | 7 |
|
1 | ||||
| Other | 5 |
|
1 | ||||
| Arthritis | 5 |
|
1 | ||||
| Inflammation, joints | 4 | 0 | |||||
| Rheumatoid Arthritis | 2 | 0 | |||||
| Muscle tension | 1 | 0 |
Mouse over the table for more information
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Side effects too severe
|
3 | 33% |
|
|
Did not seem to work
|
2 | 22% |
|
|
Expense
|
2 | 22% |
|
|
Other
|
2 | 22% |
|
|
Doctor's advice
|
1 | 11% |
|
|
Course of treatment ended
|
1 | 11% |
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Patient Evaluations
See all 4 patient evaluations
-
- lilybet
- Sex: F
- Depression: 3
- Emotional: 1
- Compulsion: 0
- Anxiety: 1
- Mania: 0
- Physical: 2
- External Stress: Severe
- 50 F
- Function: Moderate
- Distress: Low
- See profile
-
-
- lilybet
- 200 mg daily
- since Sep 09, 2008
-
Efficacy
Moderate
for Other
-
Side Effects
None
- Advice/Tips There is little or no risk of heart problems with Celebrex, contrary to what some more ignorant folks would have you think. An excellent (and currently uniqu... See full evaluation
-
- Tinner
- Sex: F
- Depression: 2
- Emotional: 4
- Compulsion: 1
- Anxiety: 2
- Mania: 1
- Physical: 3
- External Stress: Severe
- 24 F
- Function: Moderate
- Distress: Moderate
- See profile
-
-
- Tinner
- 100 mg daily
- since Oct 26, 2008
-
Efficacy
Moderate
for Arthritis
-
Side Effects
None
- Advice/Tips Works great... Slow but great! See full evaluation
See all 4 patient evaluations
Report created on November 24, 2009.